See All Slides - tctmd.com

Slides

Presentation TCT 2013

My Crystal Ball: The Future of Surgical AVR in the Era of TAVR

Presenter: Craig Smith

October 27, 2013

Presentation TCT 2013

Surgical LAA Closure: Current Status and Future Perspectives

Presenter: Krzysztof Bartus

October 27, 2013

Presentation TCT 2013

ASD Closure: Surgery versus Device Closure: Competitive or Complimentary Approaches?

Presenter: Thomas Jones

October 27, 2013

Presentation TCT 2013

Palliative at Best: A Bridge to Other Definitive Therapies

Presenter: Martyn Thomas

October 27, 2013

Presentation TCT 2013

Moderate Treatment Resistant Hypertension: A New Indication for RDN?

Presenter: David Kandzari

October 27, 2013

Presentation TCT 2013

How We Should Define "Responsiveness" to Renal Denervation Therapies

Presenter: Krishna Rocha-Singh

October 27, 2013

Presentation TCT 2013

PMS in the Japan-US HBD: Past, Present, and Future - PMDA

Presenter: Nobuhiro Handa

October 27, 2013

Presentation TCT 2013

FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-eluting Stent: Update on the FIH, TARGET I, and TARGET II Trials

Presenter: Bo Xu

October 27, 2013

Presentation

A Clinical Rule to Select Patients for Stenting vs. CEA

Presenter: Emmanuel Touz?

October 25, 2013

Presentation

Intracranial Stent Placement for Symptomatic Intracranial Stenosis as Part of a Clinical Trial vs. Outside a Clinical Trial

Presenter: Farhan Siddiq

October 24, 2013

Advertisement

Slides

My Crystal Ball: The Future of Surgical AVR in the Era of TAVR

Surgical LAA Closure: Current Status and Future Perspectives

ASD Closure: Surgery versus Device Closure: Competitive or Complimentary Approaches?

Palliative at Best: A Bridge to Other Definitive Therapies

Moderate Treatment Resistant Hypertension: A New Indication for RDN?

How We Should Define "Responsiveness" to Renal Denervation Therapies

PMS in the Japan-US HBD: Past, Present, and Future - PMDA

FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-eluting Stent: Update on the FIH, TARGET I, and TARGET II Trials

A Clinical Rule to Select Patients for Stenting vs. CEA

Intracranial Stent Placement for Symptomatic Intracranial Stenosis as Part of a Clinical Trial vs. Outside a Clinical Trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content